This paper, details the overall theoretical rationale for the program and provides perspective regarding the future role such programs should occupy in efforts directed toward the rehabilitation of the drug offender.
Get full access to this article
View all access options for this article.
References
1.
GoodmanL. and GilmanA.. The Pharmacological Basis of Therapeutics, p. 306, The MacMillan Co., New York, Fourth Edition, 1970.
2.
FreedmanA. M.FinkM.SharoffR. and ZaksA.. Cyclazocine and Methadone in Narcotic Addiction. Journal of American Medical Association202, pp. 191–194, 1967.
3.
JaffeeJ. H.. Cyclazocine in the treatment of narcotic addiction in current psychiatric therapies. Masserman, Junior Edition, pp. 147–156, Grune and Stratton, Inc., New York, 1967.
4.
JaffeeJ. A. and BrillL.. Cyclazocine, a long acting narcotic antagonist, its voluntary acceptance as a treatment modality by narcotic abusers. International Journal of Addiction, pg. 99, 1966.
5.
MartinW. R.GorodetskyC. W. and McClaneT. K.. An experimental study in the treatment of narcotic addicts with cyclazocine. Clinical Pharmacological Therapies, 7, pg. 455, 1966.
6.
KurlandA. S.WurmserL.KermanF. and KokoskiR.. American Journal of Psychiatry, 122, pp. 737–742, 1966.
7.
“Development of a Nursing Regime for an Antagonist Inmate Work Release Program”—Accepted at the Fifth Methadone Conference Washington, D.C., March 17, 1973, WiechertVictoria, R.N., Director of Nursing Services, BrahenLeonard S., Ph.D., M.D. Program Director, CaponeThomas, Ph.D., Director of Psychological Services.
8.
“Antagonist Inmate Work Release Program-Behavioral Research Design”—Accepted at the Fifth Methadone Conference, Washington, D.C., March 17, 1973, CaponeThomas, Ph.D., Director of Psychological Services, BrahenLeonard S., Ph.D., M.D. Program Director, WiechertVictoria, R.N., Director of Nursing Services.
